Intra-Cellular Therapies Investor Relations Material
Latest events
Study Result
Intra-Cellular Therapies
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Intra-Cellular Therapies Inc
Access all reports
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system. These diseases include schizophrenia and bipolar disorder, as well as other disorders such as depression and sleep disorders. The company's lead product candidate is latrepirdine, an orally available small molecule designed to be an efficacious anti-schizophrenia drug with a favorable safety profile and improved tolerability compared with existing antipsychotic treatments.
Key slides for Intra-Cellular Therapies Inc
Study Result
Intra-Cellular Therapies Inc
Corporate Presentation
Intra-Cellular Therapies Inc
Latest articles
Kevin Plank and the Rise of Under Armour
Dive into the story of Under Armour and its founder Kevin Plank, highlighting both successes and mistakes.
30 Apr 2024
Sergey Brin's Role in Shaping the Tech World
Explore Sergei Brin's journey from a Moscow immigrant to co-founding Google, detailing key developments and Alphabet's creation.
29 Apr 2024
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States